Summary: In this interview, Alucent CEO Dr. Myles Greenberg explains how they're going to use an additional raise of $35 million dollars to support clinical trials, one of which has recently begun.
Summary: In this interview, Alucent CEO Dr. Myles Greenberg explains how they're going to use an additional raise of $35 million dollars to support clinical trials, one of which has recently begun.